These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6598493)

  • 41. Metabolism of budralazine, a new antihypertensive agent. I. Identification of the metabolites of budralazine in rats.
    Moroi R; Ono K; Saito T; Sano M; Akimoto T
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2850-6. PubMed ID: 1017113
    [No Abstract]   [Full Text] [Related]  

  • 42. [Synthesis of 14C-azelastine hydrochloride].
    Scheffler G; Beckel H; Schaumlöffel E
    Arzneimittelforschung; 1983; 33(11):1515-6. PubMed ID: 6686443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arylphthalazines. Part 2: 1-(Isoquinolin-5-yl)-4-arylamino phthalazines as potent inhibitors of VEGF receptors I and II.
    Duncton MA; Piatnitski EL; Katoch-Rouse R; Smith LM; Kiselyov AS; Milligan DL; Balagtas C; Wong WC; Kawakami J; Doody JF
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1579-81. PubMed ID: 16386418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolism of budralazine, a new antihypertensive agent. II. Metabolic pathways of budralazine in rats.
    Moroi R; Ono K; Saito T; Akimoto T; Sano M
    Chem Pharm Bull (Tokyo); 1977 Apr; 25(4):830-5. PubMed ID: 880722
    [No Abstract]   [Full Text] [Related]  

  • 45. Synthesis and anticonvulsant activity of 6-alkoxy-[1,2,4]triazolo[3,4-a]phthalazines.
    Zhang L; Guan LP; Sun XY; Wei CX; Chai KY; Quan ZS
    Chem Biol Drug Des; 2009 Mar; 73(3):313-9. PubMed ID: 19207467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Unexpected anti-inflammatory activity of rigid structures derived from antihypertensive 6-arylpyridazinones. III. Synthesis and activity of 7-fluoro- and 5-keto-5H-indeno(1,2-c)pyridozines].
    Cignarella G; Loriga M; Pinna GA; Pirisi MA; Schiatti P; Selva D
    Farmaco Sci; 1982 Feb; 37(2):133-44. PubMed ID: 7067808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Arteriosclerosis: how plaque heals].
    Neumaier J
    MMW Fortschr Med; 2002 Dec; 144(51-52):9. PubMed ID: 12596673
    [No Abstract]   [Full Text] [Related]  

  • 48. PTK/ZK (Novartis).
    Drevs J
    IDrugs; 2003 Aug; 6(8):787-94. PubMed ID: 12917775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The E.L.S.A. trial: protocol of a randomized trial to explore the differential effect of antihypertensive drugs on atherosclerosis in hypertension.
    Bond G; Dal Palú C; Hansson L; Magnani B; Mancia G; Neiss A; Rahn KH; Reid JL; Rodicio JL; Safar M
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S85-7. PubMed ID: 7609514
    [No Abstract]   [Full Text] [Related]  

  • 50. Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
    Wexler RR; Greenlee WJ; Irvin JD; Goldberg MR; Prendergast K; Smith RD; Timmermans PB
    J Med Chem; 1996 Feb; 39(3):625-56. PubMed ID: 8576904
    [No Abstract]   [Full Text] [Related]  

  • 51. 1-(Azolyl)-4-(aryl)-phthalazines: novel potent inhibitors of VEGF receptors I and II.
    Kiselyov AS; Semenova M; Semenov VV; Piatnitski EL
    Chem Biol Drug Des; 2006 Nov; 68(5):250-5. PubMed ID: 17177884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on ecarazine hydrochloride (apiracohl). II. Spectrofluorometric determination of ecarazine hydrochloride and its metabolite in plasma.
    Ishii A; Deguchi T
    Chem Pharm Bull (Tokyo); 1978 Jul; 26(7):2241-6. PubMed ID: 688536
    [No Abstract]   [Full Text] [Related]  

  • 53. Synthesis of new 2-[1(2H)-phthalazinon-2-yl]acetamide and 3-[1(2H)-phthalazinon-2-yl]propanamide derivatives as antinociceptive and anti-inflammatory agents.
    Dogruer DS; Kupeli E; Yesilada E; Sahin MF
    Arch Pharm (Weinheim); 2004 Jun; 337(6):303-10. PubMed ID: 15188219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antihypertensive compounds--synthesis of 2-imino-3-(beta-hydroxyphenethyl) thiazolidine derivatives].
    Xie MH; Zhong AA; Zhang XH
    Yao Xue Xue Bao; 1983 Feb; 18(2):147-50. PubMed ID: 6613594
    [No Abstract]   [Full Text] [Related]  

  • 55. Synthesis and structure-activity relationships of 1-aminophthalazinium bromides as GABAA receptor ligands.
    Catarzi D; Cecchi L; Filacchioni G; Bartolini A; Carpenedo R; Galli A; Mori F
    Drug Des Discov; 1993; 10(1):23-34. PubMed ID: 8399992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of new derivatives of 4-hydroxy-(2H)-phthalazinone and phthalazino-1,4-(2H)(3H)-dione.
    Otto-Jaworska T
    Acta Pol Pharm; 1992; 49(4):81-3. PubMed ID: 16092441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Compliance studies in ELSA. European Lacidipine Study of Atherosclerosis.
    Giannattasio C; Boutouyrie P; Glen S; Mallion J; Reid J; Laurent S; Mancia G
    Blood Press Suppl; 1996; 4():39-43. PubMed ID: 8973782
    [No Abstract]   [Full Text] [Related]  

  • 58. Synthesis and antihypertensive activity of some 3-substituted 4H-1,2,4-triazoles.
    Emilsson H; Selander H
    Acta Pharm Suec; 1983; 20(6):419-32. PubMed ID: 6675421
    [No Abstract]   [Full Text] [Related]  

  • 59. Antihypertensive effect of 1-(3,4-methylenedioxybenzyl) 4-(1-oxobutyl)-piperazine.
    Pieri F; Sefraoui H; Arnould ML; Kirkiacharian S; Cheav SL
    Farmaco; 1995 Feb; 50(2):149-51. PubMed ID: 7766279
    [No Abstract]   [Full Text] [Related]  

  • 60. [Anti-atherosclerotic action of hypotensive drugs].
    Gmiński J; Stajszczyk M
    Wiad Lek; 1996; 49(7-12):182-98. PubMed ID: 9245114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.